Company / Operating Margin
Caris Life Sciences, Inc. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
5.6%
FY2025
5-year range
-104.4% / 5.6%
FY2023-FY2025
Trend
+108.9%
vs FY2024
Sector context
#73 of 148
Health Care
What the data says
At 5.6%, Caris Life Sciences, Inc.'s operating margin ranks #73 of 148 in the Health Care sector. Improved from -104.4% to 5.6% over the past 2 years.
Based on SEC 10-K filings.
5.6% in FY2025.
Improved from -104.4% to 5.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#73 of 148 in Health CareTop 49% of 148This company 5.6% Sector average -284.5%
▼
+102.0% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 108.9% year-over-year.
- Currently 290.0pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 5.6% | +108.9% |
| FY2024 | -62.4% | +40.2% |
| FY2023 | -104.4% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026